Gene: MYH15
Official Full Name: myosin heavy chain 15provided by HGNC
Gene Summary: Predicted to enable actin filament binding activity and microfilament motor activity. Predicted to be involved in extraocular skeletal muscle development. Located in cytosol and intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30058 | MYH15 Knockout cell line (HCT 116) | Human | MYH15 | 1:2~1:4 | Negative | Online Inquiry |
MYH15 Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate the study of myosin heavy chain 15 (MYH15) and its role in muscle physiology and pathology. The MYH15 gene encodes a protein that is crucial in the contraction of striated muscle tissues, making these knockout cell lines invaluable for understanding fundamental mechanisms of muscle biology and disorders related to myosin dysfunction.
The key function of these cell lines lies in their ability to enable researchers to explore the consequences of MYH15 loss-of-function. By utilizing CRISPR-Cas9 or similar gene-editing technologies to create targeted deletions in the MYH15 gene, scientists can investigate downstream effects on cellular morphology, signaling pathways, and overall muscle contractility. This knockout model provides a differentiated background for analyzing changes in gene expression, muscle fiber type composition, and potential compensatory mechanisms triggered by the absence of MYH15.
The scientific importance of MYH15 Gene Knockout Cell Lines extends to various applications, including fundamental muscle biology research, drug discovery, and therapeutic development, particularly for conditions such as congenital myopathies and cardiomyopathies. In clinical settings, these cell lines can serve as platforms for testing novel pharmacological agents that aim to restore normal function or correct pathophysiological states resulting from MYH15 mutations.
One of the distinct advantages of using MYH15 Gene Knockout Cell Lines is their ability to provide a controlled environment that enhances reproducibility in experimental outcomes. Unlike other available models, these knockout lines allow for a precise dissection of MYH15's specific role, leading to a deeper understanding of muscle diseases. Additionally, they can be easily scaled up for high-throughput screening applications, thereby accelerating the research timeline.
Researchers and clinicians will find significant value in these cell lines, as they present a unique opportunity to elucidate complex muscle mechanisms, validate therapeutic targets, and contribute to advancements in personalized medicine strategies. By integrating comprehensive support and detailed product information, our commitment to excellence ensures that you can rely on the MYH15 Gene Knockout Cell Lines for your research and clinical needs. With a robust background in biological product development, we are dedicated to providing high-quality models that empower scientific inquiry and foster innovation in muscle research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.